Pharmacomicrobiomics of Non-Antibiotic Drugs: Mechanisms and Clinical Consequences of Gut Microbiota Alterations

<b>Background</b>: The gut microbiota constitutes a metabolically active “second genome” that profoundly modulates drug pharmacokinetics, pharmacodynamics, and adverse reaction profiles. Beyond antibiotics, widely prescribed non-antibiotic pharmacotherapies exert clinically relevant pharmacomicrobio...

Descripció completa

Dades bibliogràfiques

Autors principals:	Caterina Nela Dumitru, Alina Oana Dumitru, Larisa Goroftei, Elena Niculet, Mariana Daniela Ignat, Liliana Baroiu, Aurel Nechita, Gabriela Balan
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2026-05-01
Col·lecció:	Pharmaceutics
Matèries:	pharmacomicrobiomics drug–microbiome interactions gut microbiota clinical pharmacology drug metabolism pharmacovigilance
Accés en línia:	https://www.mdpi.com/1999-4923/18/6/651
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!